Copyright Reports & Markets. All rights reserved.

Global Oral Contrast Agent Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Oral Contrast Agent

      • 1.1 Definition of Oral Contrast Agent
      • 1.2 Oral Contrast Agent Segment by Type
        • 1.2.1 Global Oral Contrast Agent Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Barium-based Contrast Media
        • 1.2.3 Iodinated Contrast Media
        • 1.2.4 Gadolinium-based Contrast Media
        • 1.2.5 Microbubble Contrast Media
      • 1.3 Oral Contrast Agent Segment by Applications
        • 1.3.1 Global Oral Contrast Agent Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Cardiovascular Disorders
        • 1.3.3 Cancer
        • 1.3.4 Gastrointestinal Disorders
        • 1.3.5 Musculoskeletal Disorders
        • 1.3.6 Neurological Disorders
        • 1.3.7 Nephrological Disorders
      • 1.4 Global Oral Contrast Agent Overall Market
        • 1.4.1 Global Oral Contrast Agent Revenue (2014-2025)
        • 1.4.2 Global Oral Contrast Agent Production (2014-2025)
        • 1.4.3 North America Oral Contrast Agent Status and Prospect (2014-2025)
        • 1.4.4 Europe Oral Contrast Agent Status and Prospect (2014-2025)
        • 1.4.5 China Oral Contrast Agent Status and Prospect (2014-2025)
        • 1.4.6 Japan Oral Contrast Agent Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Oral Contrast Agent Status and Prospect (2014-2025)
        • 1.4.8 India Oral Contrast Agent Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Oral Contrast Agent
      • 2.3 Manufacturing Process Analysis of Oral Contrast Agent
      • 2.4 Industry Chain Structure of Oral Contrast Agent

      3 Development and Manufacturing Plants Analysis of Oral Contrast Agent

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Oral Contrast Agent Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Oral Contrast Agent
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Oral Contrast Agent Production and Capacity Analysis
      • 4.2 Oral Contrast Agent Revenue Analysis
      • 4.3 Oral Contrast Agent Price Analysis
      • 4.4 Market Concentration Degree

      5 Oral Contrast Agent Regional Market Analysis

      • 5.1 Oral Contrast Agent Production by Regions
        • 5.1.1 Global Oral Contrast Agent Production by Regions
        • 5.1.2 Global Oral Contrast Agent Revenue by Regions
      • 5.2 Oral Contrast Agent Consumption by Regions
      • 5.3 North America Oral Contrast Agent Market Analysis
        • 5.3.1 North America Oral Contrast Agent Production
        • 5.3.2 North America Oral Contrast Agent Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Oral Contrast Agent Import and Export
      • 5.4 Europe Oral Contrast Agent Market Analysis
        • 5.4.1 Europe Oral Contrast Agent Production
        • 5.4.2 Europe Oral Contrast Agent Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Oral Contrast Agent Import and Export
      • 5.5 China Oral Contrast Agent Market Analysis
        • 5.5.1 China Oral Contrast Agent Production
        • 5.5.2 China Oral Contrast Agent Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Oral Contrast Agent Import and Export
      • 5.6 Japan Oral Contrast Agent Market Analysis
        • 5.6.1 Japan Oral Contrast Agent Production
        • 5.6.2 Japan Oral Contrast Agent Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Oral Contrast Agent Import and Export
      • 5.7 Southeast Asia Oral Contrast Agent Market Analysis
        • 5.7.1 Southeast Asia Oral Contrast Agent Production
        • 5.7.2 Southeast Asia Oral Contrast Agent Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Oral Contrast Agent Import and Export
      • 5.8 India Oral Contrast Agent Market Analysis
        • 5.8.1 India Oral Contrast Agent Production
        • 5.8.2 India Oral Contrast Agent Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Oral Contrast Agent Import and Export

      6 Oral Contrast Agent Segment Market Analysis (by Type)

      • 6.1 Global Oral Contrast Agent Production by Type
      • 6.2 Global Oral Contrast Agent Revenue by Type
      • 6.3 Oral Contrast Agent Price by Type

      7 Oral Contrast Agent Segment Market Analysis (by Application)

      • 7.1 Global Oral Contrast Agent Consumption by Application
      • 7.2 Global Oral Contrast Agent Consumption Market Share by Application (2014-2019)

      8 Oral Contrast Agent Major Manufacturers Analysis

      • 8.1 GE Healthcare (US)
        • 8.1.1 GE Healthcare (US) Oral Contrast Agent Production Sites and Area Served
        • 8.1.2 GE Healthcare (US) Product Introduction, Application and Specification
        • 8.1.3 GE Healthcare (US) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bracco Imaging (Italy)
        • 8.2.1 Bracco Imaging (Italy) Oral Contrast Agent Production Sites and Area Served
        • 8.2.2 Bracco Imaging (Italy) Product Introduction, Application and Specification
        • 8.2.3 Bracco Imaging (Italy) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Bayer HealthCare (Germany)
        • 8.3.1 Bayer HealthCare (Germany) Oral Contrast Agent Production Sites and Area Served
        • 8.3.2 Bayer HealthCare (Germany) Product Introduction, Application and Specification
        • 8.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Guerbet (France)
        • 8.4.1 Guerbet (France) Oral Contrast Agent Production Sites and Area Served
        • 8.4.2 Guerbet (France) Product Introduction, Application and Specification
        • 8.4.3 Guerbet (France) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Lantheus (US)
        • 8.5.1 Lantheus (US) Oral Contrast Agent Production Sites and Area Served
        • 8.5.2 Lantheus (US) Product Introduction, Application and Specification
        • 8.5.3 Lantheus (US) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Daiichi Sankyo (Japan)
        • 8.6.1 Daiichi Sankyo (Japan) Oral Contrast Agent Production Sites and Area Served
        • 8.6.2 Daiichi Sankyo (Japan) Product Introduction, Application and Specification
        • 8.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Unijules Life Sciences (India)
        • 8.7.1 Unijules Life Sciences (India) Oral Contrast Agent Production Sites and Area Served
        • 8.7.2 Unijules Life Sciences (India) Product Introduction, Application and Specification
        • 8.7.3 Unijules Life Sciences (India) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 J.B. Chemicals and Pharmaceuticals (India)
        • 8.8.1 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Production Sites and Area Served
        • 8.8.2 J.B. Chemicals and Pharmaceuticals (India) Product Introduction, Application and Specification
        • 8.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Spago Nanomedicine (Sweden)
        • 8.9.1 Spago Nanomedicine (Sweden) Oral Contrast Agent Production Sites and Area Served
        • 8.9.2 Spago Nanomedicine (Sweden) Product Introduction, Application and Specification
        • 8.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Taejoon Pharm (South Korea)
        • 8.10.1 Taejoon Pharm (South Korea) Oral Contrast Agent Production Sites and Area Served
        • 8.10.2 Taejoon Pharm (South Korea) Product Introduction, Application and Specification
        • 8.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Jodas (India)
      • 8.12 Magnus Health (India)

      9 Development Trend of Analysis of Oral Contrast Agent Market

      • 9.1 Global Oral Contrast Agent Market Trend Analysis
        • 9.1.1 Global Oral Contrast Agent Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Oral Contrast Agent Regional Market Trend
        • 9.2.1 North America Oral Contrast Agent Forecast 2019-2025
        • 9.2.2 Europe Oral Contrast Agent Forecast 2019-2025
        • 9.2.3 China Oral Contrast Agent Forecast 2019-2025
        • 9.2.4 Japan Oral Contrast Agent Forecast 2019-2025
        • 9.2.5 Southeast Asia Oral Contrast Agent Forecast 2019-2025
        • 9.2.6 India Oral Contrast Agent Forecast 2019-2025
      • 9.3 Oral Contrast Agent Market Trend (Product Type)
      • 9.4 Oral Contrast Agent Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Oral Contrast Agent Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Oral Contrast Agent market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Oral Contrast Agent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Contrast Agent market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Oral Contrast Agent in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Oral Contrast Agent manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        GE Healthcare (US)
        Bracco Imaging (Italy)
        Bayer HealthCare (Germany)
        Guerbet (France)
        Lantheus (US)
        Daiichi Sankyo (Japan)
        Unijules Life Sciences (India)
        J.B. Chemicals and Pharmaceuticals (India)
        Spago Nanomedicine (Sweden)
        Taejoon Pharm (South Korea)
        Jodas (India)
        Magnus Health (India)

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Barium-based Contrast Media
        Iodinated Contrast Media
        Gadolinium-based Contrast Media
        Microbubble Contrast Media

        Segment by Application
        Cardiovascular Disorders
        Cancer
        Gastrointestinal Disorders
        Musculoskeletal Disorders
        Neurological Disorders
        Nephrological Disorders

        Buy now